Skip to main content
PMC home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2007 May 9;30(5):218–222. doi: 10.1002/clc.20091

Cardiac manifestations of parasitic infections part 2: Parasitic myocardial disease

Carlos Franco‐Paredes 1,4,✉, Nadine Rouphael 1, José Méndez 2, Erik Folch 1,5, Alfonso J Rodríguez‐Morales 3, José Ignacio Santos 4, J W Hurst 2
PMCID: PMC6653741  PMID: 17492686

Abstract

This is part two of a three‐part series discussing parasites of the heart. In this section, we present an overview on parasitic diseases predominantly involving the myocardium. Copyright © 2007 Wiley Periodicals, Inc.

Keywords: heart, parasites, Chagas disease, pericardium, myocardium

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

References

  • 1.Centers for Disease Control and Prevention. Treating opportunistic infections among HIV‐1 Adults and Adolescents. MMWR 2004; 53(RR15): 1–112. [Google Scholar]
  • 2. Matturri L, Quattrone P, Varesi C, Rossi L: Cardiac toxoplasmosis in pathology of acquired immunodeficiency syndrome. Panminerva Med 1990; 32(4): 194–196. [PubMed] [Google Scholar]
  • 3. Hofman P, Drici MD, Gibelin P, Michiels JF, Thyss A: Prevalence of toxoplasma myocarditis in patients with the acquired immunodeficiency syndrome. Br Heart J 1993; 70(4): 376–381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Ryning FW, McLeod R, Maddox JC, Hunt S, Remington JS: Probable transmission of Toxoplasma gondii by organ transplantation. Ann Intern Med 1979; 90(1): 47–49. [DOI] [PubMed] [Google Scholar]
  • 5. Gallino A, Maggiorini M, Kiowski W, Martin X, Wunderli W, et al.: Toxoplasmosis in heart transplant recipients. Eur J Clin Microbiol Infect Dis 1996; 15(5): 389–393. [DOI] [PubMed] [Google Scholar]
  • 6. Mayes JT, O'Connor BJ, Avery R, Castellani W, Carey W: Transmission of Toxoplasma gondii infection by liver transplantation. Clin Infect Dis 1995; 21(3): 511–515. [DOI] [PubMed] [Google Scholar]
  • 7. Reynolds ES, Walls KW, Pfeiffer RI: Generalized toxoplasmosis following renal transplantation. Report of a case. Arch Intern Med 1966; 118(4): 401–405. [PubMed] [Google Scholar]
  • 8. Slavin MA, Meyers JD, Remington JS, Hackman RC: Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. Bone Marrow Transplant 1994; 13(5): 549–557. [PubMed] [Google Scholar]
  • 9. Mary AS, Hamilton M: Ventricular tachycardia in a patient with toxoplasmosis. Br Heart J 1973; 35(3): 349–352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Politi Okoshi M, Rubens Montenegro M: Pathology of the heart in AIDS. Study of 73 consecutive necropsies. Arq Bras Cardiol 1996; 66(3): 129–133. [PubMed] [Google Scholar]
  • 11. Wreghitt TG, Gray JJ, Pavel P, Balfour A, Fabbri A, et al.: Efficacy of pyrimethamine for the prevention of donor‐acquired Toxoplasma gondii infection in heart and heart‐lung transplant patients. Transpl Int 1992; 5(4): 197–200. [DOI] [PubMed] [Google Scholar]
  • 12. Hoffman P, Bernard E, Michiels JF, Thyss A, Le Fichoux Y, et al.: Extracerebral toxoplasmosis in the acquired immunodeficiency syndrome (AIDS). Pathol Res Pract 1993; 189(8): 894–901. [DOI] [PubMed] [Google Scholar]
  • 13. Sahasrabudhe NS, Jadhav MV, Deshmukh SD, Holla VV: Pathology of Toxoplasma myocarditis in acquired immunodeficiency syndrome. Indian J Pathol Microbiol 2003; 46(4): 649–651. [PubMed] [Google Scholar]
  • 14. Wagner FM, Reichenspurner H, Uberfuhr P, Weiss M, Fingerle V, et al.: Toxoplasmosis after heart transplantation: diagnosis by endomyocardial biopsy. J Heart Lung Transplant 1994; 13(5): 916–918. [PubMed] [Google Scholar]
  • 15. Moorhead A, Grunenwald PE, Dietz VJ, Schantz PM: Trichinellosis in the United States, 1991–1996: declining but not gone. Am J Trop Med Hyg 1999; 60(1): 66–69. [DOI] [PubMed] [Google Scholar]
  • 16. Lazarevic AM, Neskovic AN, Goronja M, Golubovic S, Komic J, et al.: Low incidence of cardiac abnormalities in treated trichinosis: a prospective study of 62 patients from a single‐source outbreak. Am J Med 1999; 107(1): 18–23. [DOI] [PubMed] [Google Scholar]
  • 17. Andy JJ, O'Connell JP, Daddario RC, Roberts WC: Trichinosis causing extensive ventricular mural endocarditis with superimposed thrombosis. Evidence that severe eosinophilia damages endocardium. Am J Med 1977; 63(5): 824–829. [DOI] [PubMed] [Google Scholar]
  • 18. Kirschberg GJ: Trichinosis presenting as acute myocardial infarction. Can Med Assoc J 1972; 106(8): 898–899. [PMC free article] [PubMed] [Google Scholar]
  • 19. Compton SJ, Celum CL, Lee C, Thompson D, Sumi SM, et al.: Trichinosis with ventilatory failure and persistent myocarditis. Clin Infect Dis 1993; 16(4): 500–504. [DOI] [PubMed] [Google Scholar]
  • 20. Siwak E, Dron D, Pancewicz S, Zajkowska J, Snarska I, et al.: Changes in ECG examination of patients with trichinosis. Wiad Lek 1994; 47(13–14): 499–502. [PubMed] [Google Scholar]
  • 21. Urbina JA, Docampo R: Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol 2003; 19(11): 495–501. [DOI] [PubMed] [Google Scholar]
  • 22. Punukollu G, Gowda RM, Khan IA: Early twentieth century descriptions of the Chagas heart disease. Int J Cardiol 2004; 95: 347–349. [DOI] [PubMed] [Google Scholar]
  • 23. de Faria JB, Alves G: Transmission of Chagas' disease through cadaveric renal transplantation. Transplantation 1993; 56(6): 1583–1584. [PubMed] [Google Scholar]
  • 24. Gurtler RE, Segura EL, Cohen JE: Congenital transmission of Trypanosoma cruzi infection in Argentina. Emerg Infect Dis 2003; 9(1): 29–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Ferreira MS, Nishioka Sde A, Silvestre MT, Borges AS, Nunes‐Araujo FR, et al.: Reactivation of Chagas' disease in patients with AIDS: report of three new cases and review of the literature. Clin Infect Dis 1997; 25: 1397–1400. [DOI] [PubMed] [Google Scholar]
  • 26. Barcan L, Lunao O, Clara L, Sinagra A, Valledor A, et al.: Transmission of T. Cruzi infection via liver transplantation to a non reactive recipient for Chagas' disease. Liver Transpl 2005; 11(9): 1112–1116. [DOI] [PubMed] [Google Scholar]
  • 27.ProMED‐mail. Trypanosomiasis, foodborne ‐ Brazil (Santa Catarina) ProMED‐mail 2005; 24 Mar: 20050324.0847. <http://www. promedmail.org>. Accessed December 31, 2006.
  • 28. Machado FS, Koyama NS, Carregaro V, Ferreira BR, Milanezi CM, et al.: CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi. J Infect Dis 2005; 191(4): 627–636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Añez N, Carrasco H, Parada H, Crisante G, Rojas A, et al.: Myocardial parasite persistence in chronic chagasic patients. Am J Trop Med Hyg 1999; 60(5): 726–732. [DOI] [PubMed] [Google Scholar]
  • 30. Elias MC, Vargas N, Tomazi L, Pedroso A, Zingales B, et al.: Comparative analysis of genomic sequences suggests that Trypanosoma cruzi CL Brenner contains two sets of non‐intercalated repeats of satellite DNA that correspond to T. cruzi I and T. cruzi II types. Mol Biochem Parasitol 2005; 140: 221–227. [DOI] [PubMed] [Google Scholar]
  • 31. Lages‐Sila E, Crema E, Ramirez LE, Macedo AM, Pena SD, et al.: Relationship between Trypanosoma cruzi and human chagasic megaesophagus: blood and tissue parasitism. Am J Trop Med Hyg 2001; 65(5): 435–441. [DOI] [PubMed] [Google Scholar]
  • 32. Pinto Dias JC: The treatment of Chagas disease (South American trypanosomiasis). Ann Intern Med 2006; 144(10): 772–774. [DOI] [PubMed] [Google Scholar]
  • 33. Rassi A Jr, Rassi SG, Rassi A: Sudden death in Chagas' disease. Arq Bras Cardiol 2001; 76(1): 75–96. [DOI] [PubMed] [Google Scholar]
  • 34. Samuel J, Oliveira M, Correa De Araujo RR, Navarro MA, Mucillo G: Cardiac thrombosis and thromboembolism in chronic Chagas' heart disease. Am J Cardiol 1983; 52(1): 147–151. [DOI] [PubMed] [Google Scholar]
  • 35. Garzon SA, Lorga AM, Nicolau JC: Electrocardiography in Chagas' heart disease. Sao Paulo Med J 1995; 113(2): 802–813. [DOI] [PubMed] [Google Scholar]
  • 36. Scanavacca M, Sosa E: Electrophysiologic study in chronic Chagas' heart disease. Sao Paulo Med J 1995; 113(2): 841–850. [DOI] [PubMed] [Google Scholar]
  • 37. Ferreira AW, de Avila SD: Laboratory diagnosis of Chagas' heart disease. Sao Paulo Med J 1995; 113(2): 767–771. [DOI] [PubMed] [Google Scholar]
  • 38. Ribeiro AL, dos Reis AM, Barros MV, de Sousa MR, Rocha AL, et al.: Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease. Lancet 2002; 360(9331): 461–462. [DOI] [PubMed] [Google Scholar]
  • 39. de Andrade AL, Zicker F, de Oliveira RM, Almeida Silva S, Luquetti A, et al.: Randomised trial of efficacy of bensnidazole in treatment of early Trypanosoma cruzi infection. Lancet 1996; 348: 1407–1413. [DOI] [PubMed] [Google Scholar]
  • 40. Villar JC, Marin‐Neto JA, Ebrahim S, Yusuf S. Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection. Cochrane Database Syst Rev 2002. 1 CD003463. [DOI] [PubMed] [Google Scholar]
  • 41. Bocchi EA, Fiorelli A: The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology. Ann Thorac Surg 2001; 71: 1833. [DOI] [PubMed] [Google Scholar]
  • 42. Moreira LF, Seferian P, Bocchi EA, Pego‐Fernandes PM, Stolf NA, et al.: Survival improvement with dynamic cardiomyoplasty in patients with dilated cardiomyopathy. Circulation 1991; 84(5 Suppl 1): III296–III302. [PubMed] [Google Scholar]
  • 43. Rodriguez H, Munoz M, Llamas G, Iturralde P, Medeiros A, et al.: Automatic, implantable cardioverter‐defibrillator in a patient with chronic Chagas cardiopathy and sustained ventricular tachycardia. Arch Inst Cardiol Mex 1998; 68(5): 391–399. [PubMed] [Google Scholar]
  • 44. Sinha A, Grace C, Alston WK, Westenfeld F, Maguire JH: African trypanosomiasis in two travelers from the United States. Clin Infect Dis 1999; 29: 840. [DOI] [PubMed] [Google Scholar]
  • 45. Moore A: Prospects for improving African trypanosomiasis chemotherapy. J Infect Dis 2005; 191: 1793–1796. [DOI] [PubMed] [Google Scholar]
  • 46. Schmid C, Richer M, Bilenge CMM, Josenando T, Chappuis F, et al.: Effectiveness of a 10‐day melarsoprol schedule for the treatment of late‐stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II). J Infect Dis 2005; 191: 1922–1931. [DOI] [PubMed] [Google Scholar]
  • 47. Bertrand E: Cardiac involvement in human African trypanosomiasis. Med Trop (Mars) 1987; 47(1): 91–93. [PubMed] [Google Scholar]
  • 48. Jones IG, Lowenthal MN, Buyst H: Electrocardiographic changes in African trypanosomiasis caused by Trypanosoma brucei rhodesiense. Trans R Soc Trop Med Hyg 1975; 69(4): 388–395. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES